Literature DB >> 12582152

Oligomerization of the human ARF tumor suppressor and its response to oxidative stress.

Sergio Menéndez1, Zeb Khan, David W Coomber, David P Lane, Maureen Higgins, Maria M Koufali, Sonia Lain.   

Abstract

The tumor suppressor ARF plays an important role as an inhibitor of the Mdm2-mediated degradation of p53. Here we demonstrate that human ARF (p14ARF) can form homo-oligomers. The stability of the oligomers is favored by oxidizing agents in a reversible fashion and involves all three cysteine residues in p14ARF. Furthermore, the effect of p14ARF in clonogenic assays is moderately but reproducibly increased by the mutation of its cysteine residues. We also observed that altering the amino terminus of p14ARF resulted in the appearance of remarkably stable oligomers. This indicates that the amino terminus of p14ARF interferes with the ability of the protein to form multimeric complexes. These observations suggest that p14ARF activity may be linked to its oligomerization status and sensitive to the redox status of the cell.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12582152     DOI: 10.1074/jbc.M211007200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Intrinsically unstructured domains of Arf and Hdm2 form bimolecular oligomeric structures in vitro and in vivo.

Authors:  Sivashankar G Sivakolundu; Amanda Nourse; Simon Moshiach; Brian Bothner; Chimere Ashley; John Satumba; Jill Lahti; Richard W Kriwacki
Journal:  J Mol Biol       Date:  2008-09-16       Impact factor: 5.469

2.  Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.

Authors:  Chandrashekhar Korgaonkar; Jussara Hagen; Van Tompkins; April A Frazier; Chantal Allamargot; Frederick W Quelle; Dawn E Quelle
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

3.  Mdm2 regulates p53 independently of p19(ARF) in homeostatic tissues.

Authors:  Kathleen A O'Leary; Susan M Mendrysa; Abram Vaccaro; Mary Ellen Perry
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

4.  N-terminal polyubiquitination and degradation of the Arf tumor suppressor.

Authors:  Mei-Ling Kuo; Willem den Besten; David Bertwistle; Martine F Roussel; Charles J Sherr
Journal:  Genes Dev       Date:  2004-08-01       Impact factor: 11.361

5.  The p53 isoforms are differentially modified by Mdm2.

Authors:  Suzanne Camus; Sergio Ménendez; Kenneth Fernandes; Nelly Kua; Geng Liu; Dimitris P Xirodimas; David P Lane; Jean-Christophe Bourdon
Journal:  Cell Cycle       Date:  2012-04-15       Impact factor: 4.534

6.  Increased hyaluronan levels in HABP1/p32/gC1qR overexpressing HepG2 cells inhibit autophagic vacuolation regulating tumor potency.

Authors:  Paramita Saha; Ilora Ghosh; Kasturi Datta
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

7.  GLTSCR2 promotes the nucleoplasmic translocation and subsequent degradation of nucleolar ARF.

Authors:  Sun Lee; Young-Eun Cho; Sang-Hoon Kim; Yong-Jun Kim; Jae-Hoon Park
Journal:  Oncotarget       Date:  2017-03-07

8.  The human ARF tumor suppressor senses blastema activity and suppresses epimorphic tissue regeneration.

Authors:  Robert G Hesse; Gayle K Kouklis; Nadav Ahituv; Jason H Pomerantz
Journal:  Elife       Date:  2015-11-17       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.